Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study

2020 ◽  
Vol 55 (2) ◽  
pp. 163-168 ◽  
Author(s):  
Eun Soo Kim ◽  
Hyun Seok Lee ◽  
Sung Kook Kim ◽  
Eun Young Kim ◽  
Byung Ik Jang ◽  
...  
2017 ◽  
Vol 152 (5) ◽  
pp. S773
Author(s):  
Dae Gon Ryu ◽  
Hyung Wook Kim ◽  
Cheol Woong Choi ◽  
Dae Hwan Kang ◽  
Su Bum Park ◽  
...  

2015 ◽  
Vol 110 (6) ◽  
pp. 873-880 ◽  
Author(s):  
Shiho Takashima ◽  
Jun Kato ◽  
Sakiko Hiraoka ◽  
Asuka Nakarai ◽  
Daisuke Takei ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-207
Author(s):  
Shiho Takashima ◽  
Jun Kato ◽  
Sakiko Hiraoka ◽  
Asuka Nakarai ◽  
Daisuke Takei ◽  
...  

2016 ◽  
Vol 150 (4) ◽  
pp. S444 ◽  
Author(s):  
Asuka Nakarai ◽  
Sakiko Hiraoka ◽  
Jun Kato ◽  
Toshihiro Inokuchi ◽  
Shiho Takashima ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Eriko Yasutomi ◽  
Toshihiro Inokuchi ◽  
Sakiko Hiraoka ◽  
Kensuke Takei ◽  
Shoko Igawa ◽  
...  

AbstractLeucine-rich alpha-2 glycoprotein (LRG) may be a novel serum biomarker for patients with inflammatory bowel disease. The association of LRG with the endoscopic activity and predictability of mucosal healing (MH) was determined and compared with those of C-reactive protein (CRP) and fecal markers (fecal immunochemical test [FIT] and fecal calprotectin [Fcal]) in 166 ulcerative colitis (UC) and 56 Crohn’s disease (CD) patients. In UC, LRG was correlated with the endoscopic activity and could predict MH, but the performance was not superior to that of fecal markers (areas under the curve [AUCs] for predicting MH: LRG: 0.61, CRP: 0.59, FIT: 0.75, and Fcal: 0.72). In CD, the performance of LRG was equivalent to that of CRP and Fcal (AUCs for predicting MH: LRG: 0.82, CRP: 0.82, FIT: 0.70, and Fcal: 0.88). LRG was able to discriminate patients with MH from those with endoscopic activity among UC and CD patients with normal CRP levels. LRG was associated with endoscopic activity and could predict MH in both UC and CD patients. It may be particularly useful in CD.


2013 ◽  
Vol 125 (3) ◽  
pp. 221-223
Author(s):  
Asuka Nakarai ◽  
Jun Kato ◽  
Sakiko Hiraoka ◽  
Motoaki Kuriyama ◽  
Toshihiro Inokuchi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document